Records containing: Type 2 Diabetes Mellitus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-04-13A 52-week Double-blind, Randomized, Placebo-controlled, Phase 2 Study to Assess the Efficacy and Safety of SAR425899 for the Treatment of Non-alcoholic Steatohepatitis (NASH)
-
CLINICAL_TRIALS study record update · 2022-04-05A Randomized, Open-Label, Parallel-Cohort, Single-dose and Multiple-dose Phase I Study of DBPR108 Tablets in Type 2 Diabetes Mellitus Patients
-
CLINICAL_TRIALS study record update · 2022-04-05Post Marketing Surveillance Protocol for Nesina® Tablet [Monotherapy or Combination Therapy in Type 2 Diabetic Patients]
-
CLINICAL_TRIALS study record update · 2022-04-01A Phase Ib Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SY-009 After Multiple Ascending Doses in Patients With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2022-03-29A Triple Cohort, Prospective Observational Study to Analyze Type 2 Diabetes Glucose Biomarkers With a Continuous Glucose Monitoring System
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-03-25This Study Evaluates the Addition of Dapagliflozin in the Treatment of Type 2 Diates With Metformin and JT-003 Combination Therapy.
-
CLINICAL_TRIALS study record update · 2022-03-17Changing Lifestyles for Better Health: A Model Program for Community Health Centers
-
CLINICAL_TRIALS study record update · 2022-03-16A Multicenter, Single-arm, Prospective Observational Study to Evaluate the Safety and Effectiveness of Gemigliptin (as Monotherapy or as Single Pill Combinations) in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2022-03-15Comparative Study of Incretin System in Three Ethnic Groups With Abnormal Glucose Tolerance
-
CLINICAL_TRIALS study record update · 2022-03-14An Open-label, Randomized, Parallel Design Trial to Compare the Efficacy of a Sitagliptin-based Metabolic Intervention Versus Standard Diabetes Therapy in Inducing Remission of Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2022-03-11AN 8-WEEK PHASE 1, RANDOMIZED, DOUBLE-BLIND, SPONSOR-OPEN, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF TWICE DAILY PF-06882961 ADMINISTRATION IN JAPANESE ADULTS WITH TYPE 2 DIABETES MELLITUS
-
CLINICAL_TRIALS study record update · 2022-03-08Effect of Resveratrol on Age-related Insulin Resistance and Inflammation in Humans
-
CLINICAL_TRIALS study record update · 2022-03-07Post-Marketing Surveillance Study on NesinaAct Tablet® Use Among Type 2 Diabetes Mellitus Patients in Korea
-
CLINICAL_TRIALS study record update · 2022-03-07This Study Evaluates the Addition of Dapagliflozin in the Treatment of Type 2 Diates With Metformin and JT-001 Combination Therapy.
-
CLINICAL_TRIALS study record update · 2022-03-02Positive Effects of Daily Consumption of Bread Enriched With Hydroxytyrosol on the Results of a 12-week Dietary Intervention on Subjects With Type 2 Diabetes Mellitus and Overweight/ Obesity
-
CLINICAL_TRIALS study record update · 2022-03-02The Effects of Prolonged Fasting on Glucose Metabolism and Hormonal Regulation in Healthy, Obese and Subjects With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2022-02-24Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in China
-
CLINICAL_TRIALS study record update · 2022-02-17The Impact of Insulin Staging in the Context of Pharmaceutical Care on Patients With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2022-02-15A Randomised Placebo-controlled Study of Fecal Microbiota Transplant (FMT) to Impact Body Weight and Glycemic Control in Obese Subjects With Type 2 Diabetes Mellitus
-
CLINICAL_TRIALS study record update · 2022-02-14Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
-
CLINICAL_TRIALS study record update · 2022-02-14Personalized Glucose Optimization Through Nutritional Intervention
-
CLINICAL_TRIALS study record update · 2022-02-14A Phase 3, Long-Term Safety Study of Tirzepatide in Combination With Monotherapy of Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus (SURPASS J-combo)
-
CLINICAL_TRIALS study record update · 2022-02-08A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2022-01-28ClinicalTrials.gov study NCT02924064
-
CLINICAL_TRIALS study record update · 2022-01-28ClinicalTrials.gov study NCT02916706